We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
The Joint Committee on Vaccination and Immunisation (JCVI) has provided interim advice to government regarding coronavirus (COVID-19) booster doses this autumn.
The JCVI is advising that people with severely weakened immune systems should have a third vaccine dose as part of their primary COVID-19 vaccination schedule.
Following the emergence of the Omicron variant, including confirmed cases in the UK, JCVI has urgently reviewed vaccine response measures.
The Joint Committee on Vaccination and Immunisation (JCVI) has issued advice to the government on the use of COVID-19 vaccines to mitigate the impact of the B1.617.2 variant of concern.
JCVI makes interim recommendations to government on the COVID-19 vaccination programme for 2023.
JCVI has advised that, in addition to those aged over 50 years and at higher risk from coronavirus, all adults aged 40 to 49 years should be offered an mRNA booster.
The Joint Committee on Vaccination and Immunisation (JCVI) has updated its vaccination advice for children aged 5 to 11, with a view to increasing protection against potential future waves of coronavirus (COVID-19).
The Joint Committee on Vaccination and Immunisation (JCVI) has considered the evidence for Phase 2 of the UK’s COVID-19 vaccination programme.
All of the available boosters provide good protection against severe illness from coronavirus (COVID-19).
A joint statement from the 4 UK health ministers on JCVI advice for phase 2 of the COVID-19 vaccination programme.
Health and Social Care Secretary Sajid Javid accepted advice from the Joint Committee on Vaccination and Immunisation (JCVI) on Wednesday 22 December 2021.
Slides presented by Professor Wei Shen Lim, Chair of the Joint Committee on Vaccination and Immunisation (JCVI) and Dr Mary Ramsay, Head of Immunisations, Public Health England.
JCVI has advised the government to invite all people on the GP Learning Disability Register for COVID-19 vaccination.
The new vaccine from HIPRA Human Health has been authorised after meeting the MHRA’s required safety, quality and effectiveness standards.
Vaccinations are to be offered to 5 to 11 year olds who are at higher risk from coronavirus (COVID-19).
How the UK government was able to build up a supply of vaccines and how it is planning to deploy them.
Health and Social Care Secretary accepts independent advice to extend booster programme to people aged 40 and over, and offer a second dose to people aged 16 to 17.
Impact assessment into the cost effectiveness of the COVID-19 autumn 2023 vaccination programme.
Precautionary measure taken to protect those most vulnerable from illness during winter following the identification of COVID-19 variant BA.2.86.
Latest updates on SARS-CoV-2 variants detected in the UK.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).